« Back to Record
Leal, T., Kotecha, R., Ramlau, R., Milanowski, J., Cobo, M., Roubec, J., Petruzelka, L., Havel, L., Kalmadi, J., Ward, J., Andrić, Z., Berghmans, T., Gerber, D. E., Kloecker, G., Panikkar, R., Aerts, J. J., Delmonte, A., Pless, M., Greil, R., Rolfo, C., A Beccara, W., Eaton, M., Iqbal, M., & Langer, C. (2023). Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study. Lancet oncology, 24, 1002-1017.
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/362469



